Lattice_grid_med
Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term therapy. Found 482 abstracts

no pagination
Boorjian SA, Blute ML. Surgery for vena caval tumor extension in renal cancer. Current opinion in urology. 2009 Sep;19(5):473-7.
Borghaei H, Smith MR, Campbell KS. Immunotherapy of cancer. European journal of pharmacology. 2009 Dec 25;625(1-3):41-54.   PMCID: PMC2783916
Coups EJ, Dhingra LK, Heckman CJ, Manne SL. Receipt of provider advice for smoking cessation and use of smoking cessation treatments among cancer survivors. J Gen Intern Med. 2009 Nov;24 Suppl 2:S480-6.   PMCID: PMC2763168
Earle CC, Weiser MR, Ter Veer A, Skibber JM, Wilson J, Rajput A, Wong YN, Benson AB, Shibata S, Romanus D, Niland J, Schrag D. Effect of Lymph Node Retrieval Rates on the Utilization of Adjuvant Chemotherapy in Stage II Colon Cancer. Journal of surgical oncology. 2009 Dec;100(7):525-8.   PMCID: not NIH funded
Egleston BL, Wong YN. Sensitivity analysis to investigate the impact of a missing covariate on survival analyses using cancer registry data. Statistics in medicine. 2009 May;28(10):1498-511.   PMCID: PMC2741403
Enders GH. Wnt therapy for bone loss: golden goose or Trojan horse?. J Clin Invest. 2009 Apr;119(4):758-60.   PMCID: PMC2662580
Engstrom PF, Arnoletti JP, Benson AB, Chen YJ, Choti MA, Cooper HS, Covey A, Dilawari RA, Early DS, Enzinger PC, Fakih MG, Fleshman J, Fuchs C, Grem JL, Kiel K, Knol JA, Leong LA, Lin E, Mulcahy MF, Rao S, Ryan DP, Saltz L, Shibata D, Skibber JM, Sofocleous C, Thomas J, Venook AP, Willett C, National Comprehensive Cancer N. NCCN Clinical Practice Guidelines in Oncology: rectal cancer. J Natl Compr Canc Netw. 2009 Sep;7(8):838-81.   PMCID: not NIH funded
Engstrom PF, Arnoletti JP, Benson AB, Chen YJ, Choti MA, Cooper HS, Covey A, Dilawari RA, Early DS, Enzinger PC, Fakih MG, Fleshman J, Fuchs C, Grem JL, Kiel K, Knol JA, Leong LA, Lin E, Mulcahy MF, Rao S, Ryan DP, Saltz L, Shibata D, Skibber JM, Sofocleous C, Thomas J, Venook AP, Willett C, National Comprehensive Cancer N. NCCN Clinical Practice Guidelines in Oncology: colon cancer. J Natl Compr Canc Netw. 2009 Sep;7(8):778-831.   PMCID: not NIH funded
Figlin RA, de Souza P, McDermott D, Dutcher JP, Berkenblit A, Thiele A, Krygowski M, Strahs A, Feingold J, Boni J, Hudes G. Analysis of PTEN and HIF-1 alpha and Correlation With Efficacy in Patients With Advanced Renal Cell Carcinoma Treated With Temsirolimus Versus Interferon-alpha. Cancer. 2009 Aug;115(16):3651-60.   PMCID: not NIH funded
Martinez E, Tatum KL, Weber DM, Kuzla N, Pendley A, Campbell K, Ridge JA, Langer C, Miyamoto C, Schnoll RA. Issues related to implementing a smoking cessation clinical trial for cancer patients. Cancer causes & control : CCC. 2009 Feb;20(1):97-104.   PMCID: PMC2628415
Meropol NJ, Schrag D, Smith TJ, Mulvey TM, Langdon RM, Blum D, Ubel PA, Schnipper LE, American Society of Clinical O. American Society of Clinical Oncology guidance statement: the cost of cancer care. J Clin Oncol. 2009 Aug 10;27(23):3868-74.
O'Brien S, Berman E, Borghaei H, DeAngelo DJ, Devetten MP, Devine S, Erba HP, Gotlib J, Jagasia M, Moore JO, Mughal T, Radich JP, Shah NP, Smith BD, Snyder DS, Talpaz M, Wetzler M. Chronic Myelogenous Leukemia. Journal of the National Comprehensive Cancer Network. 2009 Oct;7(9):984-1023.   PMCID: not NIH funded
Podoloff DA, Ball DW, Ben-Josef E, Benson AB, Cohen SJ, Coleman RE, Delbeke D, Ho M, Ilson DH, Kalemkerian GP, Lee RJ, Loeffler JS, Macapinlac HA, Morgan RJ, Siegel BA, Singhal S, Tyler DS, Wong RJ. NCCN task force: clinical utility of PET in a variety of tumor types. J Natl Compr Canc Netw. 2009 Jun;7 Suppl 2:S1-26.
Rink L, Skorobogatko Y, Kossenkov AV, Belinsky MG, Pajak T, Heinrich MC, Blanke CD, von Mehren M, Ochs MF, Eisenberg B, Godwin AK. Gene expression signatures and response to imatinib mesylate in gastrointestinal stromal tumor. Molecular Cancer Therapeutics. 2009 Aug;8(8):2172-82.   PMCID: PMC2822341
Stein R, Smith MR, Chen S, Zalath M, Goldenberg DM. Combining Milatuzumab with Bortezomib, Doxorubicin, or Dexamethasone Improves Responses in Multiple Myeloma Cell Lines. Clinical Cancer Research. 2009 Apr;15(8):2808-17.   PMCID: PMC 2681251
Wambi CO, Sanzari JK, Sayers CM, Nuth M, Zhou ZZ, Davis J, Finnberg N, Lewis-Wambi JS, Ware JH, El-Deiry WS, Kennedy AR. Protective Effects of Dietary Antioxidants on Proton Total-Body Irradiation-Mediated Hematopoietic Cell and Animal Survival. Radiation Research. 2009 Aug;172(2):175-86.   PMCID: PMC 2746923
Wong YN, Freedland SJ, Egleston B, Vapiwala N, Uzzo R, Armstrong K. The role of primary androgen deprivation therapy in localized prostate cancer. Eur Urol. 2009 Oct;56(4):609-16.   PMCID: PMC2791191
Abramowitz MC, Pollack A. Postprostatectomy radiation therapy for prostate cancer. Semin Radiat Oncol. 2008 Jan;18(1):15-22.
Ajani JA, Barthel JS, Bekaii-Saab T, Bentrem DJ, D'Amico TA, Fuchs CS, Gerdes H, Hayman JA, Hazard L, Ilson DH, Kleinberg LR, McAleer MF, Meropol NJ, Mulcahy MF, Orringer MB, Osarogiagbon RU, Posey JA, Sasson AR, Scott WJ, Shibata S, Strong VE, Swisher SG, Washington MK, Willett C, Wood DE, Wright CD, Yang G, Nccn Esophageal Cancer Panel. Esophageal cancer. J Natl Compr Canc Netw. 2008 Oct;6(9):818-49.
Bleicher RJ, Topham NS, Morrow M. Beauty and the beast: management of breast cancer after plastic surgery. Ann Surg. 2008 Apr;247(4):680-6.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term therapy

therapy Neoplasms Male diagnosis 80 and over Aged Female Aged Middle Aged methods Neoplasm Staging Physician-Patient Relations Smoking Cessation etiology Patient Education as Topic Treatment Outcome therapeutic use mortality Adult tyrosine kinase inhibitor survival epidemiology Survival Analysis complications Prostatic Neoplasms pathology agonists Wnt Proteins Adjuvant Radiotherapy Smoking Medical Societies mice Health Care Costs zinc-finger genes mtor inhibitor Biomedical Technology in-vivo targeted Esophagectomy kidney cancer renal cell carcinoma donor lymphocyte infusions Osteoporosis induced oxidative stress thrombus extension progression antitumor-activity Combined Modality Therapy x-ray-irradiation vein Sensitivity and Specificity growth Monoclonal Antibodies adverse effects radical nephrectomy Intercellular Signaling Peptides and Proteins apoptosis folinic acid cd74 stem-cell transplantation Antineoplastic Agents Cost-Benefit Analysis colorectal-cancer leukemia Esophageal Neoplasms colon cancer rectal-cancer Health Surveys numerical data Mastectomy curative resection phase-iii trial gists statistics & Dendritic Cells classification Signal Transducing Adaptor Proteins Orchiectomy radiation-injury Osteosarcoma Barrett Esophagus circulatory arrest Toll-Like Receptors Radioimmunotherapy pathway thrombectomy Drug Industry allogenic HSCT surgery Communication polymerase-chain-reaction LN retrieval diagnostic use Health Personnel response Breast Neoplasms monoclonal-antibody Local Neoplasm Recurrence venous tumor thrombus transplantation SEER Program relative biological effectiveness Positron-Emission Tomography Medical Education-Continuing kit mutations prognostic-significance Proportional Hazards Models complete cytogenetic mammalian target kinase inhibitor Prostatectomy deficiency Young Adult Registries Diagnostic Imaging Survivors chemotherapy resistance differential-diagnosis Biological Models genetics Gene Silencing Insurance Coverage Analysis of Variance ligand concentration Rectal Neoplasms Algorithms chronic myeloid-leukemia Colonic Neoplasms Statistical Data Interpretation Radiotherapy Double-Blind Method Deglutition Disorders Kidney Neoplasms Biometry prognostic-factors Adolescent nilotinib Prognosis karyotyping Health Promotion imatinib mesylate plus levamisole proteins United States T-Lymphocytes Mammaplasty Fluorodeoxyglucose F18 interleukin-8 production immunology carcinoma
Last updated on Friday, January 03, 2020